Pharmaceuticals
QUAISR APPLICATION
Oral solid dosage (OSD) process selection
End-to-end integration of heterogeneous process models.
- Challenge.
- End-to-end OSD process modelling with multiple tools and teams is challenging.
- Solution.
- Use Quaisr to streamline process selection by connecting existing modelling & simulation initiatives, supporting engineering models, financial models, sustainability models from multiple teams in one place. Optimise tablet design by integrating unit-operation simulations, material properties models, and structural performance models.
- Impact.
- Accelerate time to market by creating and sharing internal digital applications to select manufacturing processes, meet manufacturability constraints and boost operational decision support.
QUAISR APPLICATION
Sustainability compliance for manufacturing
Operational excellence with end-to-end optimisation.
- Challenge.
- Process decisions involve complex tradeoffs between operating margins, energy and material consumption.
- Solution.
- Use Quaisr to identify optimal operating conditions that maximise product yield, while minimising energy and solvent consumption. Support robust decisions using in-built surrogate modelling and multi-objective optimisation strategies. All decisions and supporting data are tracked and versioned for regulatory audit.
- Impact.
- Decrease OPEX while responding to company wide strategice objectives like low carbon emissions and sustainability.
QUAISR APPLICATION
Patient recruitment for clinical trials
Real-time aggregation of complex data sources.
- Challenge.
- Extensive statistical analysis is required to achieve balanced clinical trial populations.
- Solution.
- Use Quaisr to inform patient recruitment and aggregate data from multiple research sites, identify trends and track anomalies. Workflows are used to inform protocol design, identify incomplete records, and track data diversity. Teams reduce siloed working conditions by sharing automated workflows among internal statisticians and external contractors.
- Impact.
- Faster clinical trials while conforming to regulatory body mandates.
- 30% - 40%
- Faster design cycles
- 10% - 15%
- Reduced OPEX
- 2x - 3x
- Faster clinical trials
QUAISR APPLICATIONS
Additional solutions
- Chemicals
- Reduce physical experimentation.Supply chain carbon footprint.Virtual laboratory.
- Learn more
- Consumer Goods
- Reduce physical experimentation.Increase product shelf life.Reduce line breakdowns.
- Learn more
- Energy
- De-risk scenario planning.Offshore wind optimisation.Accelerate carbon reduction targets.
- Learn more